I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
A KRAS variant is a biomarker of poor outcome, platinum che..:
Ratner, ES
;
Keane, FK
;
Lindner, R
...
qt6n55m2gz. , 2012
Link:
https://escholarship.org/uc/item/6n55m2gz
RT Journal T1
A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer
UL https://suche.suub.uni-bremen.de/peid=base-ftcdlib:oai:escholarship.org:ark:_13030_qt6n55m2gz&Exemplar=1&LAN=DE A1 Ratner, ES A1 Keane, FK A1 Lindner, R A1 Tassi, RA A1 Paranjape, T A1 Glasgow, M A1 Nallur, S A1 Deng, Y A1 Lu, L A1 Steele, L A1 Sand, S A1 Muller, R-U A1 Bignotti, E A1 Bellone, S A1 Boeke, M A1 Yao, X A1 Pecorelli, S A1 Ravaggi, A A1 Katsaros, D A1 Zelterman, D A1 Cristea, MC A1 Yu, H A1 Rutherford, TJ A1 Weitzel, JN A1 Neuhausen, SL A1 Schwartz, PE A1 Slack, FJ A1 Santin, AD A1 Weidhaas, JB PB eScholarship, University of California YR 2012 K1 Ovarian Cancer K1 Genetics K1 Rare Diseases K1 Clinical Research K1 Cancer K1 2.1 Biological and endogenous factors K1 Aetiology K1 3' Untranslated Regions K1 Aged K1 Antineoplastic Combined Chemotherapy Protocols K1 BRCA1 Protein K1 BRCA2 Protein K1 Biomarkers K1 Tumor K1 Carboplatin K1 Cell Line K1 Cell Survival K1 Drug Resistance K1 Neoplasm K1 Female K1 Genotype K1 Humans K1 Kaplan-Meier Estimate K1 Middle Aged K1 Multivariate Analysis K1 Mutation K1 Neoplasms K1 Glandular and Epithelial K1 Ovarian Neoplasms K1 Paclitaxel K1 Polymorphism K1 Single Nucleotide K1 Prognosis K1 Proto-Oncogene Proteins K1 Proto-Oncogene Proteins p21(ras) K1 RNA Interference K1 Treatment Outcome K1 ras Proteins K1 platinum resistance K1 KRAS variant K1 outcome K1 Clinical Sciences K1 Oncology and Carcinogenesis K1 Oncology & Carcinogenesis JF qt6n55m2gz LK http://dx.doi.org/https://escholarship.org/uc/item/6n55m2gz DO https://escholarship.org/uc/item/6n55m2gz SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)